• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液透析患者中的胎球蛋白-A、炎症与冠状动脉钙化

Fetuin-A, inflammation, and coronary artery calcification in hemodialysis patients.

作者信息

Turkmen K, Gorgulu N, Uysal M, Ozkok A, Sakaci T, Unsal A, Yildiz A

机构信息

Department of Nephrology, Selcuk University Meram School of Medicine, Konya, Turkey.

出版信息

Indian J Nephrol. 2011 Apr;21(2):90-4. doi: 10.4103/0971-4065.82128.

DOI:10.4103/0971-4065.82128
PMID:21769170
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3132345/
Abstract

Hemodialysis patients have extremely increased cardiovascular mortality. Vascular calcification, inflammation, and low serum fetuin-A levels are implicated for increased mortality. In this study, relationship between coronary artery calcification, inflammation, and serum fetuin-A levels were investigated. Seventy-eight hemodialysis patients (38 male, 40 female, mean age: 52±14.5 years) were included. All patients were on dialysis for more than 6 months. Coronary artery calcium scores (CACS) are determined by electron-beam computed tomography. Serum CRP, IL-1β, IL-6, TNF-α, and serum fetuin-A levels were measured. Mean CACS value was 488.5±94.5. Serum fetuin-A levels were negatively correlated with CACS (r:-0.30, P=0.009). Patients are divided into two groups according to total CACS value; group 1 (CACS<10), group 2 (CACS≥10). There was a statistically significance difference in fetuin-A levels between CACS group 1 and group 2 (P=0.001). In this study, serum fetuin-A levels were associated with total CACS. This Fetuin-A may play a role in increased mortality in this group of patients via facilitating CAC.

摘要

血液透析患者的心血管死亡率极高。血管钙化、炎症以及血清胎球蛋白-A水平降低与死亡率增加有关。在本研究中,对冠状动脉钙化、炎症与血清胎球蛋白-A水平之间的关系进行了调查。纳入了78例血液透析患者(男性38例,女性40例,平均年龄:52±14.5岁)。所有患者均接受透析超过6个月。通过电子束计算机断层扫描确定冠状动脉钙化评分(CACS)。测量血清CRP、IL-1β、IL-6、TNF-α以及血清胎球蛋白-A水平。平均CACS值为488.5±94.5。血清胎球蛋白-A水平与CACS呈负相关(r:-0.30,P = 0.009)。根据总CACS值将患者分为两组;第1组(CACS<10),第2组(CACS≥10)。CACS第1组和第2组之间的胎球蛋白-A水平存在统计学显著差异(P = 0.001)。在本研究中,血清胎球蛋白-A水平与总CACS相关。这种胎球蛋白-A可能通过促进冠状动脉钙化在该组患者死亡率增加中起作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b32/3132345/419082f05bfd/IJN-21-90-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b32/3132345/419082f05bfd/IJN-21-90-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b32/3132345/419082f05bfd/IJN-21-90-g003.jpg

相似文献

1
Fetuin-A, inflammation, and coronary artery calcification in hemodialysis patients.血液透析患者中的胎球蛋白-A、炎症与冠状动脉钙化
Indian J Nephrol. 2011 Apr;21(2):90-4. doi: 10.4103/0971-4065.82128.
2
The relationship between coronary artery calcium scores and left atrium size in hemodialysis patients.血液透析患者冠状动脉钙化积分与左心房大小的关系。
Int Urol Nephrol. 2017 Sep;49(9):1661-1666. doi: 10.1007/s11255-017-1620-0. Epub 2017 May 18.
3
Effect of serum FGF-23, MGP and fetuin-A on calcium-phosphate metabolism in maintenance hemodialysis patients.血清成纤维细胞生长因子-23、基质Gla蛋白和胎球蛋白-A对维持性血液透析患者钙磷代谢的影响
Hemodial Int. 2013 Oct;17(4):483-92. doi: 10.1111/hdi.12033. Epub 2013 Mar 12.
4
Association among serum fetuin-A level, coronary artery calcification, and bone mineral densitometry in maintenance hemodialysis patients.维持性血液透析患者血清胎球蛋白 A 水平、冠状动脉钙化与骨密度的相关性。
Artif Organs. 2009 Oct;33(10):844-54. doi: 10.1111/j.1525-1594.2009.00814.x. Epub 2009 Jul 22.
5
Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function.多层螺旋计算机断层扫描评估肾功能正常患者血浆成纤维细胞生长因子-23、血清胎球蛋白-A水平与冠状动脉钙化之间的关系
Clin Endocrinol (Oxf). 2008 Apr;68(4):660-5. doi: 10.1111/j.1365-2265.2007.03074.x. Epub 2007 Oct 29.
6
Association of fetuin-A and cardiac calcification and inflammation levels in hemodialysis patients.血液透析患者胎球蛋白 A 与心脏钙化和炎症水平的相关性。
Scand J Clin Lab Invest. 2010 Dec;70(8):575-82. doi: 10.3109/00365513.2010.528445. Epub 2010 Oct 21.
7
The Relationship of Fetuin-A with Coronary Calcification, Carotid Atherosclerosis, and Mortality Risk in Non-Dialysis Chronic Kidney Disease.非透析慢性肾脏病中胎球蛋白-A与冠状动脉钙化、颈动脉粥样硬化及死亡风险的关系
J Lipid Atheroscler. 2024 May;13(2):194-211. doi: 10.12997/jla.2024.13.2.194. Epub 2024 Mar 7.
8
Serum S100A12 and Progression of Coronary Artery Calcification Over 4 Years in Hemodialysis Patients.血液透析患者血清S100A12与4年冠状动脉钙化进展情况
Am J Nephrol. 2015;42(1):4-13. doi: 10.1159/000438869. Epub 2015 Aug 13.
9
Fetuin-mineral complex reflects extraosseous calcification stress in CKD.胎球蛋白-矿物质复合物反映了 CKD 患者的骨外钙化应激。
J Am Soc Nephrol. 2010 Nov;21(11):1998-2007. doi: 10.1681/ASN.2009090944. Epub 2010 Oct 14.
10
Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis.高冠状动脉钙化评分(CACS)对慢性血液透析患者生存的影响。
Clin Exp Nephrol. 2004 Mar;8(1):54-8. doi: 10.1007/s10157-003-0260-0.

引用本文的文献

1
The Relationship of Fetuin-A with Coronary Calcification, Carotid Atherosclerosis, and Mortality Risk in Non-Dialysis Chronic Kidney Disease.非透析慢性肾脏病中胎球蛋白-A与冠状动脉钙化、颈动脉粥样硬化及死亡风险的关系
J Lipid Atheroscler. 2024 May;13(2):194-211. doi: 10.12997/jla.2024.13.2.194. Epub 2024 Mar 7.
2
Cardiovascular Calcifications Are Correlated with Inflammation in Hemodialysis Patients.心血管钙化与血液透析患者的炎症相关。
Medicina (Kaunas). 2023 Oct 10;59(10):1801. doi: 10.3390/medicina59101801.
3
Pathophysiology and Clinical Impacts of Chronic Kidney Disease on Coronary Artery Calcification.

本文引用的文献

1
Carotid artery calcification and atherosclerosis at the initiation of hemodialysis in patients with end-stage renal disease.终末期肾病患者血液透析起始时的颈动脉钙化和动脉粥样硬化
Clin Nephrol. 2010 May;73(5):360-9. doi: 10.5414/cnp73360.
2
Coronary artery calcification and coronary flow velocity in haemodialysis patients.血液透析患者的冠状动脉钙化和冠状动脉血流速度。
Nephrol Dial Transplant. 2010 Aug;25(8):2685-90. doi: 10.1093/ndt/gfq113. Epub 2010 Feb 26.
3
Blood pressure and vascular calcification.血压与血管钙化。
慢性肾脏病对冠状动脉钙化的病理生理学及临床影响
J Cardiovasc Dev Dis. 2023 May 10;10(5):207. doi: 10.3390/jcdd10050207.
4
Association of Serum Osteoprotegerin Level With Myocardial Injury and Cardiovascular Calcification in Chronic Kidney Disease Patients.慢性肾脏病患者血清骨保护素水平与心肌损伤及心血管钙化的相关性
Front Med (Lausanne). 2022 Jun 22;9:814970. doi: 10.3389/fmed.2022.814970. eCollection 2022.
5
Vascular calcification of chronic kidney disease: A brief review.慢性肾脏病的血管钙化:简要综述
Tzu Chi Med J. 2020 Jul 29;33(1):34-41. doi: 10.4103/tcmj.tcmj_36_20. eCollection 2021 Jan-Mar.
6
Relationship between serum osteoprotegerin and vascular calcifications in hemodialysis patients.血液透析患者血清骨保护素与血管钙化之间的关系。
Egypt Heart J. 2017 Jun;69(2):149-155. doi: 10.1016/j.ehj.2017.02.004. Epub 2017 Mar 9.
7
Neutrophil-to-lymphocyte ratio as a possible indicator of epicardial adipose tissue in patients undergoing hemodialysis.中性粒细胞与淋巴细胞比值作为血液透析患者心外膜脂肪组织的一个可能指标。
Arch Med Sci. 2017 Feb 1;13(1):118-123. doi: 10.5114/aoms.2015.50784. Epub 2016 Dec 19.
8
Association Between Hematological Indices and Coronary Calcification in Symptomatic Patients without History of Coronary Artery Disease.无冠状动脉疾病病史的有症状患者血液学指标与冠状动脉钙化之间的关联
N Am J Med Sci. 2014 Sep;6(9):433-9. doi: 10.4103/1947-2714.141625.
9
An update on coronary artery disease and chronic kidney disease.冠状动脉疾病与慢性肾脏病的最新进展
Int J Nephrol. 2014;2014:767424. doi: 10.1155/2014/767424. Epub 2014 Mar 10.
10
Soluble TWEAK independently predicts atherosclerosis in renal transplant patients.可溶性 TWEAK 可独立预测肾移植患者的动脉粥样硬化。
BMC Nephrol. 2013 Jul 12;14:144. doi: 10.1186/1471-2369-14-144.
Hypertension. 2010 Apr;55(4):990-7. doi: 10.1161/HYPERTENSIONAHA.109.147520. Epub 2010 Feb 22.
4
Association among serum fetuin-A level, coronary artery calcification, and bone mineral densitometry in maintenance hemodialysis patients.维持性血液透析患者血清胎球蛋白 A 水平、冠状动脉钙化与骨密度的相关性。
Artif Organs. 2009 Oct;33(10):844-54. doi: 10.1111/j.1525-1594.2009.00814.x. Epub 2009 Jul 22.
5
Molecular determinants of vascular calcification: a bench to bedside view.血管钙化的分子决定因素:从实验室到临床的视角
Curr Mol Med. 2006 Aug;6(5):515-24. doi: 10.2174/156652406778018653.
6
Cardiac calcifications: Fetuin-A and other risk factors in hemodialysis patients.心脏钙化:血液透析患者中的胎球蛋白-A及其他危险因素
ASAIO J. 2006 Mar-Apr;52(2):150-6. doi: 10.1097/01.mat.0000202606.44826.6b.
7
Study on the relationship of serum fetuin-A concentration with aortic stiffness in patients on dialysis.透析患者血清胎球蛋白-A浓度与主动脉僵硬度关系的研究
Nephrol Dial Transplant. 2006 May;21(5):1293-9. doi: 10.1093/ndt/gfk045. Epub 2006 Jan 5.
8
Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients.血清胎球蛋白-A与腹膜透析患者营养不良、炎症、动脉粥样硬化及瓣膜钙化综合征的关联及预后
Nephrol Dial Transplant. 2005 Aug;20(8):1676-85. doi: 10.1093/ndt/gfh891. Epub 2005 May 17.
9
Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin.胎球蛋白-A水平低与心血管死亡相关:胎球蛋白编码基因变异的影响。
Kidney Int. 2005 Jun;67(6):2383-92. doi: 10.1111/j.1523-1755.2005.00345.x.
10
Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD).钙化抑制剂在慢性肾脏病(CKD)血管钙化发病机制中的作用。
Kidney Int. 2005 Jun;67(6):2295-304. doi: 10.1111/j.1523-1755.2005.00333.x.